Efficacy and safety of deferasirox after allogeneic stem cell transplantation: results of CICL670AES04 trial

被引:0
|
作者
Vallejo, C.
Batlle, M.
Vazquez, L.
Perez-Simon, J. A.
Solano, C.
Sampol, A.
Duarte, R.
Hernandez, D.
Lopez, J.
Rovira, M.
Jimenez, S.
Valcarcel, D.
Garzon, S.
Belloch, V.
Jimenez, M.
Jarque, I.
机构
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:S343 / S343
页数:1
相关论文
共 50 条
  • [41] Safety and Efficacy of Pembrolizumab Prior to Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia
    Tschernia, Nicholas P.
    Kumar, Vaibhav
    Moore, Dominic T.
    Vincent, Benjamin G.
    Coombs, Catherine C.
    Van Deventer, Hendrik
    Foster, Matthew C.
    DeZern, Amy E.
    Luznik, Leo
    Riches, Marcie L.
    Serody, Jonathan S.
    Gojo, Ivana
    Zeidner, Joshua F.
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (12): : 1021.e1 - 1021.e5
  • [42] Efficacy and safety of micafungin for antifungal prophylaxis in patients receiving allogeneic stem cell transplantation
    Santarone, S.
    Olioso, P.
    Natale, A.
    Papalinetti, G.
    Bonfini, T.
    Accorsi, P.
    Angelini, S.
    Parruti, G.
    Di Bartolomeo, P.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S404 - S405
  • [43] Improving nutritional status after allogeneic stem cell transplantation: results of phase 2 ALLONUT clinical trial
    Estran, Sophie
    Loschi, Michael
    Benachour, Sami
    Soldati, Alizee
    Chiche, Edmond
    Sammut, Rinzine
    Robert, Guillaume
    Jacquel, Arnaud
    Chibois, Jacques
    Schneider, Stephane
    Cluzeau, Thomas
    BONE MARROW TRANSPLANTATION, 2024, 59 (07) : 957 - 964
  • [44] The prognostic value of oxygenation index early after allogeneic hematopoetic stem cell transplantation:: results of a prospective trial
    Schiemanck, CS
    Höffken, G
    Ehninger, G
    Bornhäuser, M
    Illmer, T
    BONE MARROW TRANSPLANTATION, 2003, 31 : S45 - S45
  • [45] Immunomodulatory Effect of Vitamin D after Allogeneic Stem Cell Transplantation: Results of a Prospective Multicenter Clinical Trial
    Caballero-Velazquez, Teresa
    Montero, Isabel
    Sanchez-Guijo, Fermin
    Parody, Rocio
    Saldana, Raquel
    Valcarcel, David
    Lopez-Godino, Oriana
    Ferra i Coll, Christelle
    Cuesta, Marian
    Carrillo-Vico, Antonio
    Sanchez-Abarca, Luis I.
    Lopez-Corral, Lucia
    Marquez-Malaver, Francisco J.
    Perez-Simon, Jose A.
    CLINICAL CANCER RESEARCH, 2016, 22 (23) : 5673 - 5681
  • [46] Safety and efficacy of everolimus after kidney and hematopoietic stem cell transplantation
    Keller, Frieder
    Wiesner, Susanne
    Bunjes, Donald
    Hartmann, Bertram
    Schmitt, Michael
    ANNALS OF TRANSPLANTATION, 2012, 17 (04) : 52 - 58
  • [47] DEFERASIROX USE AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PEDIATRIC PATIENTS WITH β-THALASSEMIA MAJOR: Preliminary Results
    Unal, Sule
    Kuskonmaz, Baris
    Hazirolan, Tuncay
    Eldem, Gonca
    Aytac, Selin
    Cetin, Mualla
    Uckan, Duygu
    Gumruk, Fatma
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2010, 27 (06) : 482 - 489
  • [48] The Addition of Sirolimus to GVHD Prophylaxis After Allogeneic Hematopoietic Stem Cell Transplantation: A Meta-Analysis of Efficacy and Safety
    Chen, Xiaoli
    Sun, Hengrui
    Cassady, Kaniel
    Yang, Shijie
    Chen, Ting
    Wang, Li
    Yan, Hongju
    Zhang, Xi
    Feng, Yimei
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [49] Efficacy and safety of Venetoclax in the treatment of 25 patients with recurrent hematologic malignancies after an allogeneic hematopoietic stem cell transplantation
    陈欣
    China Medical Abstracts(Internal Medicine), 2022, 39 (04) : 230 - 231
  • [50] Safety and efficacy of allogeneic stem cell transplantation after nivolumab therapy for patients with relapsed/refractory classical Hodgkin lymphoma
    Beynarovich, A.
    Lepik, K.
    Mikhailova, N.
    Kondakova, E.
    Zalyalov, Y.
    Moiseev, I.
    Afanasyev, B.
    ANNALS OF ONCOLOGY, 2019, 30 : 22 - +